Literature DB >> 19026761

Molecular pathology of age-related macular degeneration.

Xiaoyan Ding1, Mrinali Patel, Chi-Chao Chan.   

Abstract

Age-related macular degeneration (AMD) is a leading cause of irreversible blindness in the world. Although the etiology and pathogenesis of AMD remain largely unclear, a complex interaction of genetic and environmental factors is thought to exist. AMD pathology is characterized by degeneration involving the retinal photoreceptors, retinal pigment epithelium, and Bruch's membrane, as well as, in some cases, alterations in choroidal capillaries. Recent research on the genetic and molecular underpinnings of AMD brings to light several basic molecular pathways and pathophysiological processes that might mediate AMD risk, progression, and/or response to therapy. This review summarizes, in detail, the molecular pathological findings in both humans and animal models, including genetic variations in CFH, CX3CR1, and ARMS2/HtrA1, as well as the role of numerous molecules implicated in inflammation, apoptosis, cholesterol trafficking, angiogenesis, and oxidative stress.

Entities:  

Mesh:

Year:  2008        PMID: 19026761      PMCID: PMC2715284          DOI: 10.1016/j.preteyeres.2008.10.001

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  202 in total

1.  Variation near complement factor I is associated with risk of advanced AMD.

Authors:  Jesen A Fagerness; Julian B Maller; Benjamin M Neale; Robyn C Reynolds; Mark J Daly; Johanna M Seddon
Journal:  Eur J Hum Genet       Date:  2008-08-06       Impact factor: 4.246

2.  Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration.

Authors:  E M Stone; A R Webster; K Vandenburgh; L M Streb; R R Hockey; A J Lotery; V C Sheffield
Journal:  Nat Genet       Date:  1998-12       Impact factor: 38.330

3.  Chlamydia pneumoniae infection, complement factor H variants and age-related macular degeneration.

Authors:  D Shen; J Tuo; M Patel; A A Herzlich; X Ding; E Y Chew; C-C Chan
Journal:  Br J Ophthalmol       Date:  2008-11-07       Impact factor: 4.638

4.  Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy.

Authors:  M A Brantley; S L Edelstein; J M King; M R Plotzke; R S Apte; S M Kymes; A Shiels
Journal:  Eye (Lond)       Date:  2008-02-22       Impact factor: 3.775

5.  Complement factor H binds to denatured rather than to native pentameric C-reactive protein.

Authors:  Svetlana Hakobyan; Claire L Harris; Carmen W van den Berg; Maria Carmen Fernandez-Alonso; Elena Goicoechea de Jorge; Santiago Rodriguez de Cordoba; German Rivas; Palma Mangione; Mark B Pepys; B Paul Morgan
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

6.  Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis.

Authors:  Ronald Klein; Michael D Knudtson; Barbara E K Klein; Tien Y Wong; Mary Frances Cotch; Kiang Liu; Ching Y Cheng; Gregory L Burke; Mohammed F Saad; David R Jacobs; A Richey Sharrett
Journal:  Ophthalmology       Date:  2008-06-05       Impact factor: 12.079

7.  Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study.

Authors:  Sarah Ennis; Catherine Jomary; Robert Mullins; Angela Cree; Xiaoli Chen; Alex Macleod; Stephen Jones; Andrew Collins; Edwin Stone; Andrew Lotery
Journal:  Lancet       Date:  2008-10-06       Impact factor: 79.321

8.  The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples.

Authors:  Jingsheng Tuo; Robert J Ross; George F Reed; Qing Yan; Jie Jin Wang; Christine M Bojanowski; Emily Y Chew; Xiao Feng; Timothy W Olsen; Frederick L Ferris; Paul Mitchell; Chi-Chao Chan
Journal:  Ophthalmology       Date:  2008-08-21       Impact factor: 12.079

9.  Toll-like receptor 3 and geographic atrophy in age-related macular degeneration.

Authors:  Zhenglin Yang; Charity Stratton; Peter J Francis; Mark E Kleinman; Perciliz L Tan; Daniel Gibbs; Zongzhong Tong; Haoyu Chen; Ryan Constantine; Xian Yang; Yuhong Chen; Jiexi Zeng; Lisa Davey; Xiang Ma; Vincent S Hau; Chi Wang; Jennifer Harmon; Jeanette Buehler; Erik Pearson; Shrena Patel; Yuuki Kaminoh; Scott Watkins; Ling Luo; Norman A Zabriskie; Paul S Bernstein; Wongil Cho; Andrea Schwager; David R Hinton; Michael L Klein; Sara C Hamon; Emily Simmons; Beifeng Yu; Betsy Campochiaro; Janet S Sunness; Peter Campochiaro; Lynn Jorde; Giovanni Parmigiani; Donald J Zack; Nicholas Katsanis; Jayakrishna Ambati; Kang Zhang
Journal:  N Engl J Med       Date:  2008-08-27       Impact factor: 91.245

10.  Age-related macular degeneration.

Authors:  Hanna R Coleman; Chi-Chao Chan; Frederick L Ferris; Emily Y Chew
Journal:  Lancet       Date:  2008-11-22       Impact factor: 79.321

View more
  252 in total

1.  Copy number variations in candidate genes in neovascular age-related macular degeneration.

Authors:  Melissa M Liu; Elvira Agrón; Emily Chew; Catherine Meyerle; Frederick L Ferris; Chi-Chao Chan; Jingsheng Tuo
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-16       Impact factor: 4.799

2.  Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration.

Authors:  Aihua Liu; James Chang; Yanhua Lin; Zhengqing Shen; Paul S Bernstein
Journal:  J Lipid Res       Date:  2010-08-05       Impact factor: 5.922

Review 3.  Age-related macular degeneration: genetic and environmental factors of disease.

Authors:  Yuhong Chen; Matthew Bedell; Kang Zhang
Journal:  Mol Interv       Date:  2010-10

4.  Absence of DJ-1 causes age-related retinal abnormalities in association with increased oxidative stress.

Authors:  Vera L Bonilha; Brent A Bell; Mary E Rayborn; Ivy S Samuels; Anna King; Joe G Hollyfield; Chengsong Xie; Huaibin Cai
Journal:  Free Radic Biol Med       Date:  2017-01-11       Impact factor: 7.376

5.  The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment.

Authors:  Y Wang; V M Wang; C-C Chan
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

Review 6.  'Statins in retinal disease'.

Authors:  Ahmed Al-Janabi; Sue Lightman; Oren Tomkins-Netzer
Journal:  Eye (Lond)       Date:  2018-03-20       Impact factor: 3.775

7.  Angiogenic and Immunologic Proteins Identified by Deep Proteomic Profiling of Human Retinal and Choroidal Vascular Endothelial Cells: Potential Targets for New Biologic Drugs.

Authors:  Justine R Smith; Larry L David; Binoy Appukuttan; Phillip A Wilmarth
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

8.  Inhibition of development of laser-induced choroidal neovascularization with suppression of infiltration of macrophages in Smad3-null mice.

Authors:  Hiroki Iwanishi; Norihito Fujita; Katsuo Tomoyose; Yuka Okada; Osamu Yamanaka; Kathleen C Flanders; Shizuya Saika
Journal:  Lab Invest       Date:  2016-03-07       Impact factor: 5.662

Review 9.  Next-generation therapeutic solutions for age-related macular degeneration.

Authors:  Khrishen Cunnusamy; Rafael Ufret-Vincenty; Shusheng Wang
Journal:  Pharm Pat Anal       Date:  2012-05

10.  FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression.

Authors:  Leah A Owen; Margaux A Morrison; Jeeyun Ahn; Se Joon Woo; Hajime Sato; Rosann Robinson; Denise J Morgan; Fani Zacharaki; Marina Simeonova; Hironori Uehara; Usha Chakravarthy; Ruth E Hogg; Balamurali K Ambati; Maria Kotoula; Wolfgang Baehr; Neena B Haider; Giuliana Silvestri; Joan W Miller; Evangelia E Tsironi; Lindsay A Farrer; Ivana K Kim; Kyu Hyung Park; Margaret M DeAngelis
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.